(EFXT) Enerflex - Ratings and Ratios
Compression, Processing, Cryogenic, Water-Treatment, After-Market
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.74% |
| Yield on Cost 5y | 2.05% |
| Yield CAGR 5y | 12.37% |
| Payout Consistency | 90.2% |
| Payout Ratio | 7.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 47.3% |
| Value at Risk 5%th | 69.4% |
| Relative Tail Risk | -10.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.03 |
| Alpha | 24.07 |
| CAGR/Max DD | 0.60 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.407 |
| Beta | 1.272 |
| Beta Downside | 2.239 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.26% |
| Mean DD | 21.68% |
| Median DD | 23.69% |
Description: EFXT Enerflex November 17, 2025
Enerflex Ltd. (NYSE:EFXT) is a Calgary-based provider of integrated energy-infrastructure and transition solutions across North America, Latin America, and the Eastern Hemisphere. Its product suite covers compression, processing, cryogenic, and treated-water systems, and it offers end-to-end services-from front-end engineering and design through construction, commissioning, and long-term after-market support-including contract operations, equipment optimization, and warranty programs.
Key operating metrics show FY 2023 revenue of roughly US$1.2 billion with an EBITDA margin near 15%, while the company’s backlog exceeded US$2.5 billion, reflecting strong demand for natural-gas processing and low-carbon projects such as CCUS and modular power generation. The business is sensitive to natural-gas consumption trends, U.S. capital-expenditure cycles in midstream infrastructure, and regulatory incentives for emissions-reduction technologies, which together drive order flow and pricing power.
For a deeper, data-driven assessment of Enerflex’s valuation and risk profile, consider exploring the detailed analyst toolkit on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (189.3m TTM) > 0 and > 6% of Revenue (6% = 211.2m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -5.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.62% (prev 5.43%; Δ 3.19pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 279.0m > Net Income 189.3m (YES >=105%, WARN >=100%) |
| Net Debt (914.2m) to EBITDA (541.3m) ratio: 1.69 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (122.4m) change vs 12m ago -1.44% (target <= -2.0% for YES) |
| Gross Margin 23.13% (prev 19.90%; Δ 3.23pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 102.0% (prev 112.0%; Δ -9.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.17 (EBITDA TTM 541.3m / Interest Expense TTM 87.2m) >= 6 (WARN >= 3) |
Altman Z'' 1.73
| (A) 0.08 = (Total Current Assets 1.57b - Total Current Liabilities 1.26b) / Total Assets 3.97b |
| (B) 0.07 = Retained Earnings (Balance) 265.8m / Total Assets 3.97b |
| (C) 0.11 = EBIT TTM 363.7m / Avg Total Assets 3.45b |
| (D) 0.29 = Book Value of Equity 683.2m / Total Liabilities 2.37b |
| Total Rating: 1.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.01
| 1. Piotroski 4.50pt |
| 2. FCF Yield 8.79% |
| 3. FCF Margin 6.22% |
| 4. Debt/Equity 0.62 |
| 5. Debt/Ebitda 1.69 |
| 6. ROIC - WACC (= 5.26)% |
| 7. RoE 15.59% |
| 8. Rev. Trend 85.30% |
| 9. EPS Trend 47.49% |
What is the price of EFXT shares?
Over the past week, the price has changed by -5.04%, over one month by +3.98%, over three months by +30.59% and over the past year by +46.43%.
Is EFXT a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EFXT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.1 | 1.7% |
| Analysts Target Price | 15.1 | 1.7% |
| ValueRay Target Price | 17.4 | 17.1% |
EFXT Fundamental Data Overview January 03, 2026
P/E Trailing = 11.7818
P/E Forward = 14.5985
P/S = 0.755
P/B = 1.6272
Beta = 2.026
Revenue TTM = 3.52b USD
EBIT TTM = 363.7m USD
EBITDA TTM = 541.3m USD
Long Term Debt = 648.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.6m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 914.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.49b USD (1.58b + Debt 1.00b - CCE 89.1m)
Interest Coverage Ratio = 4.17 (Ebit TTM 363.7m / Interest Expense TTM 87.2m)
FCF Yield = 8.79% (FCF TTM 219.0m / Enterprise Value 2.49b)
FCF Margin = 6.22% (FCF TTM 219.0m / Revenue TTM 3.52b)
Net Margin = 5.38% (Net Income TTM 189.3m / Revenue TTM 3.52b)
Gross Margin = 23.13% ((Revenue TTM 3.52b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 22.14% (prev 22.60%)
Tobins Q-Ratio = 0.63 (Enterprise Value 2.49b / Total Assets 3.97b)
Interest Expense / Debt = 1.99% (Interest Expense 20.0m / Debt 1.00b)
Taxrate = 40.32% (34.8m / 86.3m)
NOPAT = 217.0m (EBIT 363.7m * (1 - 40.32%))
Current Ratio = 1.24 (Total Current Assets 1.57b / Total Current Liabilities 1.26b)
Debt / Equity = 0.62 (Debt 1.00b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 1.69 (Net Debt 914.2m / EBITDA 541.3m)
Debt / FCF = 4.17 (Net Debt 914.2m / FCF TTM 219.0m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.77% (Net Income 189.3m / Total Assets 3.97b)
RoE = 15.59% (Net Income TTM 189.3m / Total Stockholder Equity 1.21b)
RoCE = 19.53% (EBIT 363.7m / Capital Employed (Equity 1.21b + L.T.Debt 648.0m))
RoIC = 12.26% (NOPAT 217.0m / Invested Capital 1.77b)
WACC = 7.00% (E(1.58b)/V(2.58b) * Re(10.70%) + D(1.00b)/V(2.58b) * Rd(1.99%) * (1-Tc(0.40)))
Discount Rate = 10.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.64%
[DCF Debug] Terminal Value 59.50% ; FCFE base≈259.6m ; Y1≈170.4m ; Y5≈77.9m
Fair Price DCF = 8.65 (DCF Value 1.05b / Shares Outstanding 121.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 47.49 | EPS CAGR: 0.11% | SUE: -0.47 | # QB: 0
Revenue Correlation: 85.30 | Revenue CAGR: 38.20% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.039 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=+0.196 | Revisions Net=+1 | Growth EPS=+42.7% | Growth Revenue=-1.8%
Additional Sources for EFXT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle